Pasithea Therapeutics Corp. Common Stock KTTA
$0.48
+0.52%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $3.00
- Implied Upside
- +524.3%
- Price Target Range
- $3.00 – $3.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-16 | HC Wainwright & Co.Sara Nik |
Reiterates | Buy | $3 |
| 2026-04-20 | HC Wainwright & Co.Sara Nik |
Reiterates | Buy | $3 |
| 2025-12-08 | HC Wainwright & Co.Sara Nik |
Initiates coverage on | Buy | $3 |
| 2023-07-10 | EF HuttonElemer Piros |
Reiterates | Buy | $40 |
| 2023-06-01 | EF HuttonElemer Piros |
Assumes | Buy | $40 |
| 2023-04-03 | EF HuttonConstantine Davides |
Maintains | Buy | $46 → $40 |
| 2021-12-14 | EF HuttonConstantine Davides |
Initiates coverage on | Buy | $65 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.48
- Market Cap
- $16.06 million
- 52-Week Range
- $0.28 – $2.06
- Average Volume
- 299K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.